Medullary thyroid carcinoma is a relatively rare thyroid cancer accounting for about 5% to 10% of all thyroid cancers.

Medullary thyroid carcinoma is a relatively rare thyroid cancer accounting for about 5% to 10% of all thyroid cancers.
Increased rates of thyroid cancer among World Trade Center (WTC)-exposed firefighters and emergency medical service personnel who participated in rescue/recovery efforts after 9/11 are likely due to medical surveillance rather than an actual increase in disease. This is the conclusion of a recently published study in JAMA Internal Medicine (https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2764101) in which investigators found excess […]
Otolaryngologist patients with medullary thyroid cancer should not be taking GLP-1 medications at this time due to the risk.
An expert panel reviewed the main changes to thryoid cancer management from molecular testing to surveillance in select cases, and from nerve monitoring to the choice between total thyroidectomy over hemi-thyroidectomy for certain tumors.
It is evident that BRAF does predict recurrence and unfavorable characteristics in differentiated thyroid cancers (DTC).
Most of the increase in incidence of thyroid cancer is related to factors that promote early diagnosis of low-risk lesions.
The rapid increase in thyroid cancer incidence rates over the past three decades has recently slowed
Investigators from around the country presented their findings at the 120th Annual Meeting of the Triological Society
The use of neck ultrasounds, radioiodine scans, and PET scans in people diagnosed with thyroid cancer was associated with additional treatment for recurrence.